Properties
Description
LY2606368 is an CDK kinase inhibitor that disrupts cell division processes. It targets Chk1, Chk1, and Chk2.
Molecular Weight
365.38916
Molecular Formula
C18H19N7O2
Targets
Chk1: 0.9 nM (Ki); Chk1: <1 nM; Chk2: 8 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
LY2606368 can be used to explore its dual inhibition of CHK1 and CHK2, and its implications for cancer treatment.
